Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events.

Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events. Med Decis Making. 2018 05; 38(4):427-438.

View in: PubMed

subject areas

Aspirin
Cardiovascular Diseases
Cost-Benefit Analysis
Data Interpretation, Statistical
Decision Support Techniques
Dose-Response Relationship, Drug
Humans
Platelet Aggregation Inhibitors
Quality-Adjusted Life Years
Research Design
Secondary Prevention

authors with profiles

David Meltzer